These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6425013

  • 1. Therapy of aluminum overload (I).
    Pierides AM, Myli MP.
    Contrib Nephrol; 1984; 38():65-77. PubMed ID: 6425013
    [No Abstract] [Full Text] [Related]

  • 2. Therapy of aluminium overload (II).
    Ackrill P, Day JP.
    Contrib Nephrol; 1984; 38():78-80. PubMed ID: 6713902
    [No Abstract] [Full Text] [Related]

  • 3. Prophylaxis and methods for early recognition of aluminium intoxication.
    Fuchs C, Armstrong VW, Quellhorst E, Scheler F.
    Contrib Nephrol; 1984; 38():81-94. PubMed ID: 6713903
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
    Milliner DS, Hercz G, Miller JH, Shinaberger JH, Nissenson AR, Coburn JW.
    Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical and biochemical features of aluminum-related bone disease.
    Ihle BU, Becker GJ, Kincaid-Smith PS.
    Kidney Int Suppl; 1986 Feb; 18():S80-6. PubMed ID: 3458003
    [No Abstract] [Full Text] [Related]

  • 9. Osteomalacia and bone disease arising from aluminum.
    Coburn JW, Norris KC, Nebeker HG.
    Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
    Mudde AH, Roodvoets AP, Van Groningen K.
    Neth J Med; 1985 Mar; 28(1):6-11. PubMed ID: 3974771
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of desferrioxamine in the treatment of dialysis encephalopathy.
    Ackrill P, Ralston AJ, Day JP.
    Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Aluminum-induced osteomalacia in chronic hemodialysis].
    Smetana S, Popovtzer MM, Bar-Khayim Y.
    Harefuah; 1987 Jun 15; 112(12):595-7. PubMed ID: 3428727
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.